https://www.avient.com/sites/default/files/2024-06/Infant Care Product Bulletin_Selector Guide.pdf
GLS™ TPE
INFANT CARE SOLUTIONS
REGULATORY COMPLIANT
MATERIALS FOR YOUR
BABY CARE PRODUCTS
GRADE PRODUCT HARDNESS REGULATORY COMPLIANCE* – FDA, EU, GB
Versaflex™
CL2242
Pacifiers
Teething
43
Shore A
FDA 177.1210 — —
Versaflex™
CL2250
Pacifiers
Teething
50
Shore A
FDA 177.1210 — —
Versaflex™
FFC 2882-87
Bottles
Food Sets
Utensils
87
Shore A
FDA 177.2600 EU 10/2011 GB 9685-2008
Versaflex™
FFC 2882-50
Bottles
Food Sets
Utensils
50
Shore A
FDA 177.2600 EU 10/2011 —
Dynaflex™
G2701C
Bottles
Food Sets
Utensils
66
Shore A
FDA 177.2600 — —
Dynaflex™
G6770
Bottles
Food Sets
Utensils
69
Shore A
FDA 177.2600 EU 10/2011 GB 9685-2008
Dynaflex™
G2780C
Bottles
Food Sets
Utensils
84
Shore A
FDA 177.2600 — —
Dynaflex™
G7600 series
Bottles
Food Sets
Utensils
30A-80 Shore
A
FDA 177.1210 — —
Dynalloy™
GP 7810 & 7820
Bathtubs
Bibs
Placemats
30A-70 Shore
A
General FDA — —
We believe that the smallest consumers deserve the very best.
https://www.avient.com/sites/default/files/2025-01/Firearms Product Selection Guide.pdf
ENGINEERED POLYMER SOLUTIONS - FEATURES & CHARACTERISTICS
Resin Nymax™ Formulations Characteristics Applications
PA6 GF 600 A 14 Natural 14% Glass Reinforced
Stocks, Frames,
Receivers,
Handguards,
Forearms,
Picatinny Rails, Grips
PA6 GF 600 A 33 Natural 33% Glass Reinforced, Heat Stabilized
PA6 NM6000-0026 HI BK 33% Glass Reinforced, Toughened
PA6 GF 600 A 60 UV Black 60% Glass Reinforced, Heat Stabilized
PA6 GF 600 A 33 Black 28 V 33% Glass Reinforced, Heat Stabilized, UV
PA6 1010 A Black 13 Super Toughened, Heat Stabilized
PA6 1010 A Natural Super Toughened, Heat Stabilized
PA6 NM6000-0027 ST Black Super Toughened
PA6 NM6000-00013 HS UV Black 50% GF, High Flow PA6
PA66 NM6600-0018 HI HS 14 Nat 14% Glass Reinforced, Toughened, Heat Stabilized
PA66 GF 1200 A 33 HS Black 22 33% Glass Reinforced, Heat Stabilized
PA66 GF 1200 A 33 HS Natural 33% Glass Reinforced, Heat Stabilized
PA66 NM6600-0019 HI HS 33 Nat 33% Glass Reinforced, Toughened, Heat Stabilized
PA66 NM6600-0020 HI HS 43 Nat 43% Glass Reinforced, Heat Stabilized
PA66 1200 A L Natural Unreinforced
PA66 1200 A ZIP 22 Natural Unreinforced
PA66 NM6600-0021 ST Black Super Toughened
PA66 NM 1200 MT HS Black Toughened, Heat Stabilized
PA66 NM 1200 MT HS Natural Toughened, Heat Stabilized
Specialty Products Color Characteristics Applications
Edgetek™ ET6200-0031 Black Black 20% Glass Reinforced PA12
Stocks, Frames, Receivers, Handguards, Forearms,
Picatinny Rails, Bolt Carriers, Grips
Gravi-Tech™ X GT 33991-05A-01-3 Copper 3sg, PA6, Copper
Gravi-Tech™ X GT-30197-001-P4 Gray 4sg, PA610, Tungston
Gravi-Tech™ GT 6400-0001 GRV 5.0 Black 5sg, PA610, Tungston
Thermoplastic Elastomers Durometer OM Substrate Color Characteristics Applications
OnFlex™ AF 7210 25-90A PP Black/Natural General Purpose with UV Stabilizer
Grips,
Recoil Pads,
Gun Straps
Dynaflex™ G7900 30-90A PP Black/Natural General Purpose
Versaflex™ XP 2850 50A PP Natural Wet Grip Technology
Versaflex™ VDT 4202-40 40A PP Black/Natural Vibration Damping
Versaflex™ VDT 5120-40 40A PA Black/Natural Vibration Damping
Versaflex™ OM6059-9 60A PA Black High Flow
Versaflex™ OM6258 60A PA Black/Natural Enhanced Bond
https://www.avient.com/news/polyone-features-more-materials-approach-medical-devices-mdm-west-2020
Versaflex™ HC Thermoplastic Elastomers: high-performance medical-grade formulations for demanding applications, including medical tubing, gaskets and stoppers, and bags, bottles and films.
The portfolio also boasts the addition of Versaflex™ HC BT218, a new biopharmaceutical tubing grade developed in response to supply challenges and sterilization concerns for an array of medical devices
https://www.avient.com/idea/material-cuts-delays-contact-lens-container-production
The manufacturer worked with Avient to formulate a custom Versaflex™ TPE that featured a low durometer with excellent resistance to adhesion (sticking).
But before making the decision to switch from silicone to the Versaflex material, the company needed to feel confident that it would recoup its capital, which included a $50,000 investment in new tooling, within 12 months.
https://www.avient.com/knowledge-base/article/overmolding-part-design
Versaflex
Most GLS styrenic TPEs (Dynaflex and some Versaflex) have fairly high mold shrinkage and cause the overmolding TPE to contract more than the substrate, which can result in warpage or cupping of the substrate part.
https://www.avient.com/idea/sealing-medical-device-savings
The resulting custom-formulated grades of GLS™ Dynalloy™ OBC and Versaflex™ TPE allowed the manufacturer to switch to a two-shot molding process that eliminated the time-consuming and costly assembly operations needed for the old part.
Reduced assembly costs: Switching to Dynalloy™ OBC and Versaflex™ TPE allowed the introduction of two-shot molding, which eliminated a multi-component assembly process.
https://www.avient.com/industries/healthcare/catheter-materials-medical-tubing/medical-tubing
Versaflex™ HC Thermoplastic Elastomers
The lower extractable profile of Versaflex™ HC BT218 thermoplastic elastomer provided a drop-in material replacement with excellent clarity and performance for a medical tubing extruder
Versaflex™ HC & Versaflex™ HC BIO TPEs - BT Series
https://www.avient.com/industries/healthcare/drug-delivery-systems/prefilled-syringes
Versaflex™ HC Thermoplastic Elastomers
Versaflex™ HC 2110-57B enhanced long-term sealing performance for disposable syringe plunger (English language version)
Versaflex™ HC 2110-57B enhanced long-term sealing performance for disposable syringe plunger (Spanish language version)
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
F E B R U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great
Place to Work® culture
Strategic Objectives
Long Term
Growth
Rates
Growth Drivers
$340
$455
$790
$1,135
2016 2018 2020 2023
$51
$84
$212
$645
2016 2018 2020 2023
$108 $113
$231 $230
2016 2018 2020 2023
$265
$358
$726 $725
2016 2018 2020 2023
8-12% 8-10% 8-10% 5%
Sustainable Solutions Composites Healthcare Asia/Emerging Regions
Profitable Growth Great Place to Work
5.4%
10.9%
16.0%
2006 2014 2023
EBITDA Margins
$0.14
$1.93
$2.36
2006 2014 2023
Adjusted EPS
TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE
AND RE COGNIT ION
Industry Sustainability Standards
ESG Ratings Performance
1
2
4
87th
94th
percentile
5
Avient CDP Score:
A-
F E B R U A R Y 1 4 , 2 0 2 4
W E B C A S T
P R E S E N T AT I O N
DR.
AS HIS H KHANDP UR
P R E S I D E N T & C E O
7
8
PORTFOLIO TRANSFORMATION
8
7%
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
E
B
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
9
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
( % O F C O M PA N Y S A L E S )
ENERGY
5%
DEFENSE
7%
TELECOMMUNICATIONS
4%
HEALTHCARE
7%
10
TRANSPORTATION
10%
INDUSTRIAL
16%
BUILDING &
CONSTRUCTION 9%
CONSUMER
19%
PACKAGING
23%
11
REGIONAL OBSERVATIONS
( % O F C O M PA N Y S A L E S )
11
US & Canada
Latin America
EMEA
Asia
41%
36%
18%
5%
Q 4 2 0 2 3 R E S U L T S
Q4 2023 PERFORMANCE VS.
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
F E B R U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great
Place to Work® culture
Strategic Objectives
Long Term
Growth
Rates
Growth Drivers
$340
$455
$790
$1,135
2016 2018 2020 2023
$51
$84
$212
$645
2016 2018 2020 2023
$108 $113
$231 $230
2016 2018 2020 2023
$265
$358
$726 $725
2016 2018 2020 2023
8-12% 8-10% 8-10% 5%
Sustainable Solutions Composites Healthcare Asia/Emerging Regions
Profitable Growth Great Place to Work
5.4%
10.9%
16.0%
2006 2014 2023
EBITDA Margins
$0.14
$1.93
$2.36
2006 2014 2023
Adjusted EPS
TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE
AND RE COGNIT ION
Industry Sustainability Standards
ESG Ratings Performance
1
2
4
87th
94th
percentile
5
Avient CDP Score:
A-
F E B R U A R Y 1 4 , 2 0 2 4
W E B C A S T
P R E S E N T AT I O N
DR.
AS HIS H KHANDP UR
P R E S I D E N T & C E O
7
8
PORTFOLIO TRANSFORMATION
8
7%
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
E
B
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
9
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
( % O F C O M PA N Y S A L E S )
ENERGY
5%
DEFENSE
7%
TELECOMMUNICATIONS
4%
HEALTHCARE
7%
10
TRANSPORTATION
10%
INDUSTRIAL
16%
BUILDING &
CONSTRUCTION 9%
CONSUMER
19%
PACKAGING
23%
11
REGIONAL OBSERVATIONS
( % O F C O M PA N Y S A L E S )
11
US & Canada
Latin America
EMEA
Asia
41%
36%
18%
5%
Q 4 2 0 2 3 R E S U L T S
Q4 2023 PERFORMANCE VS.